ARTICLE | Clinical News
Illumigene C regulatory update
October 11, 2010 7:00 AM UTC
Health Canada approved Meridian's illumigene C. difficile molecular amplification assay to detect Clostridium difficile infection. The test detects the presence of the toxin-producing region from the ...